Synaptic Blockers

Synaptic blockers are drugs, toxins, or experimental compounds that disrupt communication between neurons or between neurons and their target cells, making them important tools in neuroscience. They act by preventing neurotransmitter release, blocking postsynaptic receptors, or altering ion channels that generate and propagate synaptic signals. By selectively interrupting excitatory or inhibitory transmission, these agents help researchers identify the roles of specific synapses, neural circuits, and neurotransmitter systems. Synaptic blockers also support studies of neuromuscular function, sensory processing, and neurological disease, while informing the development and evaluation of treatments that modify abnormal neuronal signaling.

Synaptic Blockers - Related Videos

Research

JoVE Journal - Neuroscience

Studying Synaptic Vesicle Pools using Photoconversion of Styryl Dyes

0 Views •

Cited by 18 •

2010

FM dyes have been of invaluable help in the understanding of synaptic dynamics. FMs are normally followed under the fluorescent microscope during different stimulation conditions. However, photoconversion of FM dyes combined with electron microscopy allows the visualization of distinct synaptic vesicle pools, among other ultrastructure components, in synaptic boutons.

Assessing Muscle Contraction with Neuromuscular Blocker Treatment

0 Views •

2025

This video demonstrates assessing the muscle using cultured motor neurons, Schwann cells, and myotubes, followed by treatment with a neuromuscular blocker to inhibit contraction. Color-coded time-motion graphics show a color-coded time-motion graphic. Red indicates the fastest movement, and blue indicates the slowest.

Intravenous Delivery of Receptor Blockers to Reduce Brain Edema in a Mouse Model

0 Views •

2025

Source: Zeynalov, E. et. al., Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema. J. Vis. Exp. (2016)This video demonstrates the intravenous delivery of an arginine-vasopressin (AVP) receptor antagonist in a mouse model. Transient middle cerebral artery occlusion induces brain edema. An AVP receptor antagonist is administered through a catheter in the left jugular vein, alleviating edema.

Education

JoVE Core - Pharmacology

Depolarizing Blockers: Pharmocokinetics

0 Views •

2023

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...

Research

JoVE Journal - Neuroscience
Free Sample

Vibrodissociation of Neurons from Rodent Brain Slices to Study Synaptic Transmission and Image Presynaptic Terminals

0 Views •

Cited by 17 •

2011

This report demonstrates a technique for mechanical isolation of individual viable neurons retaining attached presynaptic boutons. Vibrodissociated neurons have the advantages of rapid production, excellent pharmacological control and improved space-clamp without influence from neighboring cells. This method can be used for imaging of synaptic elements and patch-clamp recording.

View All Results

FAQs

Related Topics